Ovid Therapeutics Inc. OVID
NASDAQ · United States · Health Technology
$2.43-0.06 (-2.41%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.08 | -0.12 | +30.4% | $733.00K | +3,320.6% | +8.0%$2.62→$2.83 |
| Q1 2026 | 2026-05-12 | -0.12 | -0.11 | -9.1% | — | — | +0.4%$2.79→$2.80 |
| Q4 2025 | 2026-03-18 | 0.06 | -0.10 | +160.0% | — | — | +14.4%$2.01→$2.30 |
| Q3 2025 | 2025-11-12 | -0.17 | -0.15 | -13.3% | — | — | -11.1%$1.35→$1.20 |
| Q4 2024 | 2025-03-11 | -0.13 | -0.17 | +23.5% | — | — | — |
| Q4 2023 | 2024-03-08 | -0.22 | 0.25 | -188.0% | — | — | — |
| Q3 2023 | 2023-11-03 | -0.16 | -0.19 | +15.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.